Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
The intricate chemistry behind modern pharmaceuticals often plays a direct role in alleviating common health issues. For individuals experiencing the challenges of an overactive bladder (OAB), treatments like Solifenacin offer significant relief. The production of Solifenacin relies on a precisely synthesized intermediate: Ethyl (1S)-1-Phenyl-3,4-Dihydroisoquinoline-2-Carboxylate, identified by CAS 180468-42-2.
Solifenacin functions as a muscarinic M3 receptor antagonist, effectively reducing involuntary bladder contractions. This targeted action helps patients manage symptoms such as urinary urgency, frequency, and incontinence. The development of Solifenacin highlights the crucial role of advanced organic synthesis in creating molecules that can precisely interact with biological targets. The intermediate, Ethyl (1S)-1-Phenyl-3,4-Dihydroisoquinoline-2-Carboxylate, provides the essential structural framework required for Solifenacin's pharmacological activity.
The synthesis of this intermediate, and subsequently Solifenacin, involves sophisticated chemical processes. Manufacturers focus on achieving high levels of chemical and chiral purity to ensure the drug's efficacy and safety. This involves meticulous control over reaction conditions, purification techniques, and analytical testing. The consistent production of this key intermediate is a vital part of the pharmaceutical supply chain, ensuring that patients have access to effective OAB treatments. The demand for such intermediates is closely tied to the prevalence of the condition and the success of the therapeutic agents they help create.
As research in medicinal chemistry continues, the development of more efficient and sustainable synthesis methods for critical intermediates like Ethyl (1S)-1-Phenyl-3,4-Dihydroisoquinoline-2-Carboxylate remains a priority. Innovations in catalysis, green chemistry, and process intensification can lead to improved product quality, reduced environmental impact, and more cost-effective production. Ultimately, these advancements in chemical synthesis contribute to making essential medications more accessible and improving the quality of life for patients suffering from conditions like overactive bladder.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
